232 related articles for article (PubMed ID: 19909531)
21. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
[TBL] [Abstract][Full Text] [Related]
22. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
[TBL] [Abstract][Full Text] [Related]
23. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.
Bhide SA; Gulliford S; Kazi R; El-Hariry I; Newbold K; Harrington KJ; Nutting CM
Radiother Oncol; 2009 Dec; 93(3):539-44. PubMed ID: 19883951
[TBL] [Abstract][Full Text] [Related]
24. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
25. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
26. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT).
Peponi E; Glanzmann C; Willi B; Huber G; Studer G
Radiat Oncol; 2011 Jan; 6():1. PubMed ID: 21208415
[TBL] [Abstract][Full Text] [Related]
27. Pharyngeal Constrictor Dose-Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy.
Paetkau O; Weppler S; Kwok J; Quon HC; Gomes da Rocha C; Smith W; Tchistiakova E; Kirkby C
Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):173-182. PubMed ID: 38220581
[TBL] [Abstract][Full Text] [Related]
28. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
29. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
[TBL] [Abstract][Full Text] [Related]
30. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
[TBL] [Abstract][Full Text] [Related]
32. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
Setton J; Lee NY; Riaz N; Huang SH; Waldron J; O'Sullivan B; Zhang Z; Shi W; Rosenthal DI; Hutcheson KA; Garden AS
Cancer; 2015 Jan; 121(2):294-301. PubMed ID: 25286832
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.
Maguire PD; Papagikos M; Hamann S; Neal C; Meyerson M; Hayes N; Ungaro P; Kotz K; Couch M; Pollock H; Tepper J
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1081-8. PubMed ID: 20378262
[TBL] [Abstract][Full Text] [Related]
34. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
[TBL] [Abstract][Full Text] [Related]
35. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
36. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy.
Kawamura M; Yoshimura M; Asada H; Nakamura M; Matsuo Y; Mizowaki T
Radiat Oncol; 2019 Jan; 14(1):14. PubMed ID: 30665451
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.
Wopken K; Bijl HP; Langendijk JA
Radiother Oncol; 2018 Jan; 126(1):56-67. PubMed ID: 28943045
[TBL] [Abstract][Full Text] [Related]
38. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
40. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
